27 Nov 2001
A new database for GPs could shave £500m a year off the NHS prescription bill if widely implemented, according to its developers.
Scriptswitch is the brainchild of AKM Software, a privately owned startup based in Warwickshire, which is so confident of its product that it is giving it away free and taking 20 per cent of the savings the software makes.
The PC-based package is already in pilot trials in surgeries across the UK, and may even find customers in the US and Japan, according to Andrew Bodsworth, a founding director at AKM.
"We have had a lot of support from the Department of Trade and Industry in building alliances in Japan and the US," he said.
Scriptswitch contains a database of drugs and medical information, and is designed to guide the GP into prescribing the most cost-effective treatment.
"It's not just a question of finding the cheapest drug," said Bodsworth. "Doctors can't always be up to date with medical developments. For instance we may recommend one slow release tablet a day instead of two faster acting tablets, saving a third on cost."
He explained that in trials the package had managed to cut overall prescription costs by 10 per cent. The annual prescription bill for the NHS is £5bn. "If everyone used the system, we could theoretically save the NHS £500m," Bodsworth said. "And that's without looking at appliances and dressings."
He added that AKM is currently negotiating to recruit a sales force to handle the product across the UK.
Latest stories from Developer
Related videos
Related articles
Related jobs
Poll
What will be the biggest change to corporate technology in the future?
TFL director of Games transport Mark Evers discusses how the public transport network is preparing for this summer's event
Connect with V3.co.uk
The wrong printers, for the wrong tasks on the wrong contracts
Who leads the BI pack and who should we be watching out for?
HTML, CSS, Flash - Web Content Editor - Photoshop, Dreamweaver...
Biomass Programme Manager/Engineering/Supply Chain/Heavy...
Head of Compliance My client is currently seeking...
THis role is working for a multi national Financial organisation...
Keep up to date with the latest products, services and technologies from the world's leading IT companies. IThound.com brings you over 2,000 white papers, case studies and analyst reports.
Do you agree?
Scriptswitch
My concern with this product is that people may be prescribed products that are determined to be more "cost effective" yet are worse for the patient than the original prescription. Individuals may be prescribed something more addictive in nature that is more "cost effective: than the original suggestion. The idea that medications should now be decided on the basis of cost effectiveness as opposed to which prescription will treat the individual the best and is less likely to be abused should be the consideration to what a person will be prescribed.
Posted by: Dale Baker 31 Jul 2008